Table 1.
CNV | Class | Total | Var_num | Var_per (%) | Novar_num | Novar_per (%) | P value | Odds ratio |
---|---|---|---|---|---|---|---|---|
ALK_GAIN | Hypermutation | 633 | 5 | 0.79 | 628 | 99.21 | 0.0290771 | 4.916107 |
Low | 1857 | 3 | 0.16 | 1854 | 99.84 | |||
CDK4_GAIN | Hypermutation | 633 | 31 | 4.90 | 602 | 95.10 | 5.13E-06 | 0.4267569 |
Low | 1857 | 200 | 10.77 | 1657 | 89.23 | |||
EGFR_GAIN | Hypermutation | 633 | 68 | 10.74 | 565 | 89.26 | 0.001678634 | 0.642541 |
Low | 1857 | 293 | 15.78 | 1564 | 84.22 | |||
KRAS_GAIN | Hypermutation | 633 | 21 | 3.32 | 612 | 96.68 | 0.02631793 | 0.5784877 |
Low | 1857 | 104 | 5.60 | 1753 | 94.40 | |||
MET_GAIN | Hypermutation | 633 | 21 | 3.32 | 612 | 96.68 | 0.03308558 | 0.5904969 |
Low | 1857 | 102 | 5.49 | 1755 | 94.51 | |||
PIK3CA_GAIN | Hypermutation | 633 | 103 | 16.27 | 530 | 83.73 | 5.70E-08 | 2.148361 |
Low | 1857 | 154 | 8.29 | 1703 | 91.71 |
Var_num, Number of variation; Var_per, Percentage of variation; Novar_num, Number of no variation; Novar_per, Percentage of no variation; P value and odds ratio were tested using Fisher’s analysis.